Neuroptix Corporation

News

Jan 28 2008		Neuroptix Corp. Announces Addition of Michael Henry and Stephen DiPalma to Board
Jul 16 2007		Neuroptix Announces $1 Million Milestone Payment in Collaboration with Merck & Co., Inc., for Early Detection and Monitoring of Alzheimer’s Disease Process
Apr 09 2007		Neuroptix Opens New Corporate Headquarters in Acton
Jan 18 2007		Neuroptix Expands Executive Team, Adds Evan Sherr as Vice President, Product Management, and Vincent Valvo as Vice President, Engineering and Product Development
Jan 18 2007		Neuroptix Announces Successful $1.6 Million Series A Funding Round
Dec 04 2006		Merck and Neuroptix Collaborate on Early Alzheimer’s Diagnostics Using Laser Eye Scanning
Sep 13 2006		Neuroptix Announces Breakthrough Preclinical Tests of QEL™ Platform for Non-Invasive Early Detection of Alzheimer’s
Jan 23 2006		Neuroptix Announces Successful Angel Investment Round Led by Launchpad Venture Group
Mar 08 2004		Neuroptix Announces Availability of Preclinical Research Instrument
Dec 15 2003		Neuroptix Announces Clinical Trial Agreement
Apr 12 2003		Neuroptix Announces Publication of Key Data in Peer Reviewed Lancet Article